South East Asia Defibrillators Market Size, Share & Trends Analysis Report By Product (EDs, ICDs), By End Use (Hospital, Public Access Market, Alternate Care Market), By Region, And Segment Forecasts, 2024 - 2030

South East Asia Defibrillators Market Size, Share & Trends Analysis Report By Product (EDs, ICDs), By End Use (Hospital, Public Access Market, Alternate Care Market), By Region, And Segment Forecasts, 2024 - 2030


South East Asia Defibrillators Market Growth & Trends

The South East Asia defibrillators market size is anticipated to reach USD 371.88 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 8.83% from 2024 to 2030. The SEA defibrillator market’s growth is propelled by several critical factors, including technological advancements, rising cases of cardiac arrests, favorable government initiatives and healthcare policies.

Physical inactivity is a major public health concern as it has led to the second-highest number of deaths after the consumption of tobacco globally. A sedentary lifestyle leads to morbidity and the development of chronic conditions, such as diabetes and cardiac disorders. Physical inactivity is often associated with aggravation of symptoms of chronic conditions, including atherosclerotic and diabetic patients. Major consequences of this lifestyle are cardiac disorders, such as myocardial infarction, stroke, and angina. Most of the population suffering from cardiac disorder symptoms are thus advised at least 150 minutes of physical activity daily with a minimum of 75 minutes, especially in men. According to WHO, around 2 million people die annually due to physical inactivity, and around 60.0% to 85.0% of individuals globally follow sedentary lifestyles, making it a major public health concern.

Defibrillators such as implantable cardioverter defibrillators (ICDs), automated external defibrillators (AEDs), and wearable cardioverter defibrillators, cater to a diverse range of patients from adults to pediatrics. The demand for defibrillators in SEA is on the rise due to increasing awareness of cardiovascular diseases and sudden cardiac arrest incidents. This growing demand drives imports as local manufacturing may not meet the required supply levels. According to Volza Philippines Import data, 982 defibrillator shipments were imported by 155 Philippine Importers from 235 Suppliers, primarily from China, Hong Kong, and the United States. The top importers were India, Vietnam, and Brazil.

South East Asia Defibrillators Market Report Highlights
  • Based on product, the external defibrillator segment commanded the most significant revenue share, accounting for 53.61%, in 2023
  • The growing elderly population, the incorporation of advanced technology, increased investments from both government and private manufacturers, and heightened awareness campaigns about cardiovascular disorders all contribute to the increased utilization of external defibrillators, propelling the growth of the external defibrillator segment
  • Based on end use, the hospital segment is dominant due to its investment in advanced technology to enhance emergency response capabilities and maintain compliance with global healthcare standards
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End Use
1.2.3. Country Scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. End Use Outlook
2.2.3. Region Outlook
2.3. Competitive Insights
Chapter 3. SEA Defibrillator Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising Prevalence of Cardiovascular Diseases (CVDs)
3.2.1.2. Increasing Awareness and Training Regarding Sudden Cardiac Arrest (SCA)
3.2.1.3. Government Initiatives and Regulations Promoting Public Access
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Advanced Defibrillators
3.3. SEA CGM Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. SEA CGM Market: Product Estimates & Trend Analysis
4.1. SEA CGM Market: Product Dashboard
4.2. SEA CGM Market: Product Movement Analysis
4.3. SEA CGM Market by Product, Revenue
4.4. Implantable Cardioverter Defibrillator (ICD)
4.4.1. Implantable Cardioverter Defibrillator (ICD) market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. S-ICD
4.4.2.1. S-ICD market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. T-ICD
4.4.2.2.1. T-ICD market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2.2. Single Chamber
4.4.2.2.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2.3. Dual Chamber
4.4.2.2.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2.4. CRT-D
4.4.2.2.4.1. CRT-D market estimates and forecasts 2018 to 2030 (USD Million)
4.5. External Defibrillator
4.5.1. External Defibrillator market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Manual ED
4.5.2.1. Manual ED market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Automated ED
4.5.3.1. Automated ED market estimates and forecasts 2018 to 2030 (USD Million)
4.5.4. Wearable cardioverter defibrillators
4.5.4.1. Wearable cardioverter defibrillators market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. SEA Defibrillator Market: End Use Estimates & Trend Analysis
5.1. SEA Defibrillator Market: End Use Dashboard
5.2. SEA Defibrillator Market: End Use Movement Analysis
5.3. SEA Defibrillator Market Estimates and Forecasts, By End Use, Revenue (USD Million)
5.4. Hospitals
5.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Pre hospital
5.5.1. Pre hospital market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Public Access market
5.6.1. Public Access market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Alternate care market
5.7.1. Alternate care market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Home healthcare
5.8.1. Home healthcare market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. South East Asia Defibrillator Market: Regional Market Analysis, By Product, By End Use, 2018 - 2030 (USD Million)
6.1. Definition & Scope
6.2. Regional Market Share Analysis, 2022 & 2030
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Market Size, & Forecasts, Volume And Trend Analysis, 2022 To 2030
6.6. South East Asia
6.6.1. South East Asia CGM Market, 2018 - 2030 (USD Million)
6.6.2. Singapore
6.6.2.1. Singapore CGM Market, 2018 - 2030 (USD Million)
6.6.3. Philippines
6.6.3.1. Philippines CGM Market, 2018 - 2030 (USD Million)
6.6.4. Thailand
6.6.4.1. Thailand CGM Market, 2018 - 2030 (USD Million)
6.6.5. Malaysia
6.6.5.1. Malaysia CGM Market, 2018 - 2030 (USD Million)
6.6.6. Indonesia
6.6.6.1. Indonesia CGM Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company/Competition Categorization
7.2. Vendor Landscape
7.2.1. List of key distributors and channel partners
7.2.2. Key company market share analysis, 2023
7.2.3. Medtronic
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. St. Jude Medical, LLC
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Boston Scientific Corporation
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Philips
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Zoll Medical Corporation
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Cardiac Science
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Physio-Control Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Nihon Kohden Corporation
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Progetti Srl
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. FUKUDA DENSHI
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. Schiller AG
7.2.13.1. Company overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings